H1N1
-
Agilent: Automating Viral RNA Genotyping
Agilent Automation Solutions has released an applications bulletin that describes an automated system for rapid characterization of pathogens, including for example the Influenza A (H1N1) virus. The BioCel Polymerase Chain Reaction (PCR) Viral Gen…
H1N1 | 12 April 2010
-
Swine Flu: Proving ground for Vaccine Adjuvants?
Within the pharmaceutical sector, vaccines were traditionally regarded as low-margin products. However, with the decline of Big Pharma’s traditional small molecule blockbuster model and a marked swing towards biologics, vaccines have regained appre…
H1N1 | 15 October 2009
-
Treating H1N1: Innovation Behind the Science
Information technology aids in the prediction of drug development trends.
H1N1 | 01 October 2009
-
Sinovac Obtains Production License for H1N1 Vaccine
Sinovac Biotech has announced that the State Food and Drug Administration (SFDA) has approved the registration application for Panflu.1, a H1N1 vaccine, and has issued a production license for this vaccine. Following results which showed that the …
H1N1 | 09 September 2009
-
PCR Technology for Flu Surveillance
Rapid, sensitive and accurate testing is needed to combat and contain the influenza H1N1 virus.
H1N1 | 01 September 2009
-
GlaxoSmithKline: Government Orders for Pandemic (H1N1) 2009 Vaccine
GlaxoSmithKline (GSK) has confirmed that it has contracts in place to supply 195 million doses of its pandemic (H1N1) 2009 adjuvanted influenza vaccine. It has a variety of agreements in place with the US government to supply pandemic products worth …
H1N1 | 10 August 2009
-
Veredus Laboratories: Quick Identification of H1N1 Virus
Veredus Laboratories has announced that the VereFlu chip has been tested successfully on confirmed pandemic H1N1-2009 influenza positive samples, in a joint trial with the Singapore National Public Health Laboratory (NPHL). The chip, based on STMi…
H1N1 | 13 July 2009
-
Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry
With the outbreak of H1N1 influenza in several countries, people are aware of the importance of vaccine. According to Frost & Sullivan's research in the Chinese vaccine market, the Compound Annual Growth Rate (CAGR) of the pharmaceutical industry…
H1N1 | 26 June 2009
-
Sanofi Pasteur Lands US$190 Million Order from the US Government
Sanofi Pasteur has received the first of what is expected to be a series of orders from the US Department of Health and Human Services (HHS) to commence production of an influenza A(H1N1) vaccine. This order from HHS was issued pursuant to an exis…
H1N1 | 29 May 2009
-
Briefing on H1N1 (Swine Flu) Influenza
The Healthcare and Science business of Thomson Reuters has announced the free availability of its Disease Briefing on Influenza. The daily briefing can be downloaded from http://science.thomsonreuters.com/pharma/h1n1/, and provides information on …
H1N1 | 28 May 2009
